Biological E Ltd. on Saturday announced that its Covid-19 vaccine Corbevax has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose.
A press release from the vaccine maker said the Corbevax can be administered as a booster dose to individuals aged 18 years and above after six months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for restricted use in emergency situation.
BE's Corbevax is the first such vaccine in India to be approved as a heterologous Covid-19 booster in the country, it said.
Amid confusion over the Maharashtra government's latest communication on the use of masks, Health Minister Rajesh Tope on Saturday told reporters it was only an appeal and masks have not been made mandatory in the state.
The state health department on Friday issued a letter to district and civic authorities, asking them to ramp up testing and advising people to wear masks in enclosed spaces such as trains, buses, cinemas, auditoriums, offices, hospitals, colleges and schools.
